In Vitro Diagnostics News and Research

RSS

Ortho Clinical Diagnostics announces launch and availability of VITROS XT 3400 Chemistry System

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the launch and availability of the VITROS XT 3400 Chemistry System, which completes the company's VITROS XT Solutions, a comprehensive suite of solutions that help labs obtain consistently fast, accurate and reliable results.

From Ortho-Clinical Diagnostics, Inc. 27 Feb 2020

Promega's custom manufacturing capabilities support rapid development of Logix Smart COVID-19 Test

Promega Corporation is being recognized by Utah-based Co-Diagnostics, Inc.

From Promega Corporation 26 Feb 2020

A glance at Pittcon 2020 exhibitors

The Lee Company’s LPD Series variable volume dispense pumps are stepper motor driven, positive displacement pumps that are designed to meet the demands of modern-day applications: consistent long-term performance and reliability in a compact lightweight package.

From Pittcon 21 Feb 2020

EKF’s Hemo Control hemoglobin analyzer used to reduce anemia in South America

EKF Diagnostics, announces it is supporting the reduction of anemia in developing regions of South America through the use of its POC hemoglobin analyzers.

From EKF Diagnostics 29 Jan 2020

Hitachi’s diagnostic imaging business will strengthen Fujifilm’s product line, says GlobalData

Following the news that Japan’s Fujifilm Holdings Corp has agreed to acquire Hitachi Ltd.’s diagnostic imaging business for approximately JPY179bn (US$1.64bn); Rohit Anand, Practice Head of Medical Devices at GlobalData, a leading data and analytics company, offers his view.

2 Jan 2020

FDA clears existing tests with new indications to aid in the diagnosis of Lyme disease

Today, the U.S. Food and Drug Administration cleared for marketing four previously cleared tests with new indications to aid in the diagnosis of Lyme disease.

30 Jul 2019

Luxia Scientific partners with Life Genomics to commercialize microbiome-based tests in the Nordic countries

Luxia Scientific, a French biotech dedicated to improving wellbeing and health for all through the analysis and understanding of the microbiome, announced today that it has signed an exclusive distribution agreement with Life Genomics to commercialize « 1test1TM » in Nordic countries.

From Luxia Scientific 25 Mar 2019

Luxia Scientific announces availability of its gut microbiome test in Luxembourg

Luxia Scientific, a French biotech dedicated to improving well-being and health for all through the analysis and understanding of the microbiome, announces the availability of its test “1test1” in Luxembourg. The test was launched in France beginning of October 2018.

15 Nov 2018

FDA permits marketing of 23andme Personal Genome Service Pharmacogenetic Reports test

Today, the U.S. Food and Drug Administration permitted marketing, with special controls, of the 23andme Personal Genome Service Pharmacogenetic Reports test as a direct-to-consumer test for providing information about genetic variants that may be associated with a patient's ability to metabolize some medications to help inform discussions with a health care provider.

1 Nov 2018

Image Cytometry Technology and Tissue Analysis

Image cytometry or tissue cytometry, not only measures the size, diameter and shape of a cell, but quantifies the molecular marker expression.

From TissueGnostics 4 Sep 2018

Ortho Clinical Diagnostics receives FDA approval for two hepatitis B assays

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, has received approval from the U.S. Food and Drug Administration for Ortho's VITROS Immunodiagnostic Products HBeAg Assay and the VITROS Immunodiagnostic Products Anti-HBe Assay for use on Ortho's VITROS 3600 Immunodiagnostic System and Ortho's VITROS 5600 Integrated System.

31 Jul 2018

EKF Diagnostics to showcase new Stanbio GA assay kit at AACC 2018

EKF, announces it will highlight a new Stanbio Chemistry Glycated Albumin assay kit and its newly FDA cleared DiaSpect Tm hemoglobin point of care analyzer.

From EKF Diagnostics 31 Jul 2018

Festo launches next-generation liquid handling/modular dosing system

Festo introduces its next-generation liquid handling/modular dosing system developed to simplify automating applications for in-vitro diagnostics, cell and genome research, and sample inspection.

27 Jul 2018

Quick adoption of new diagnostic tests could help NHS to save nearly £7 billion

Research commissioned by Innovate UK and the British In Vitro Diagnostics Association reveals that the NHS could save over £6.9 billion in five years through quick adoption of new diagnostic tests as they come onto the market. In turn, these savings could help tackle the annual NHS shortfall, widely expected to reach £20 billion by 2022.

20 Jun 2018

$FDA authorizes marketing of OsteoDetect software for detecting wrist fractures$

FDA authorizes marketing of OsteoDetect software for detecting wrist fractures

Today, the U.S. Food and Drug Administration permitted marketing of Imagen OsteoDetect, a type of computer-aided detection and diagnosis software designed to detect wrist fractures in adult patients.

25 May 2018

BD introduces new informatics and automation solutions for clinical laboratories

BD (Becton, Dickinson and Company), a leading global medical technology company, today introduced several new informatics and automation solutions for clinical laboratories, which may play a critical role in the fight against infectious diseases and antimicrobial resistance.

From BD (Becton, Dickinson and Company) 20 Apr 2018

TradeShow Talks with Cyanagen

We are Cyanagen, an Italian company, here at Analytica in hall A3 booth 416. We produce reagents for molecular biology, mainly ECL substrates for Western blot analyzers and fluorescent reagents for several applications.

From Cyanagen Srl 12 Apr 2018

Tradeshow Talks with POREX

News Medical talk to POREX to find out why they are exhibiting at analytica 2018.

From Porex Corporation 11 Apr 2018

Oxford Gene Technology announces leadership changes

Oxford Gene Technology, The Molecular Genetics Company, has announced that on 1st April 2018 Dr John Anson who has been with the company since 2006 as EVP of R&D took over as CEO from Dr Mike Evans, who has become a non-executive director of OGT’s board.

From Oxford Gene Technology 10 Apr 2018

Porex to display innovations in laboratory liquid handling, diagnostics and chromatography at Analytica 2018

At next month’s Analytica event, Porex Corporation will display new solutions for laboratory and medical professionals that improve accuracy and purity in liquid handling, speed fluid transfer of diagnostics and optimize chromatography operations.

From Porex Corporation 31 Mar 2018